维普期刊资源整合服务平台（V6.5）

53篇 您的检索式：作者名="Khan TM"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Mechanisms of acquired crizotinib resistance in ALK-rearranged lung cancers显示文摘	Katayama R Shaw AT Khan TM	2012	Sci Transl Med2012，4，12：	1
2	Intraosseous infusion and pulmonary fat embolism显示文摘	Hasan MY Kissoon N Khan TM	2001	Pediatr Crit Care Med2001，2，2：	1
3	Factors associated with suicidal behaviour among depressed patients in Penang, Malaysia 显示文摘	Khan TM Sulaiman SA Hassali MA	2012	Arch Med Sci2012，8，4：	1
4	Mechanisms of acquiredcrizotinib resistance in ALK-rearranged lung Cancers 显示文摘	Katayama R Shaw AT Khan TM	2012	SciTransl Med2012，4，120：	1
5	Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers har- boring the fusion oncogene EML4-ALK 显示文摘	Katayama R Khan TM Benes C	2011	Proc Nad Acad Sci USA2011，108，18：	1
6	Therapeutic strategies toovercome crizotinib resistance in non-small cell lung cancersharboring the fusion oncogene EML4-ALK 显示文摘	Katayama R Khan TM Benes C	2011	Proc Natl AcadSci USA2011，108，18：	1
7	Acute kidney injury and chronic kidney disease显示文摘	Khan TM Khan KN	2015	Vet Pathol2015，52，3：	1
8	Arterial problems associated with dysfunctional hemodialysis grafts: evaluation of patients at high risk for arterial disease显示文摘	Khan FA Vesely TM	2002	J Vasc Interv Radiol2002，13，11：	1
9	Precocious puberty in children 显示文摘	Atta I Laghari TM Khan YN	2015	J Coil Physicians Surg Pak2015，25，2：	1
10	Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EMIA-ALK显示文摘	Katayama R Khan TM Benes C	2011	Proc Natl Acad Sci USA2011，108，18：	1
11	Mechanisms of ac-quired crizotinib resistance in ALK-rearranged lung Cancers显示文摘	Katayama R Shaw AT Khan TM	2012	Sci Transl Med2012，4，120：	1
12	Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EMIA-ALK显示文摘	KATAYAMA R KHAN TM BENES C	2011	Proc Natl Acad Sci USA2011，108，18：	1
13	Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers har- boring the fusion oncogene EML4-ALK显示文摘	Katayama R Khan TM Benes C etal	2011	PNAS2011，108，18：	1
14	Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers显示文摘	Katayama R Shaw AT Khan TM	2012	Sci Transl Med2012，4，120：	1
15	Therapeutic strategiesto overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK 显示文摘	Katayama R Khan TM Benes C	2011	Proc Natl Acad Sci U S A2011，108，18：	1
16	Comparison of plas- ma viscosity and fibrinogen concentration in hypertensive and normotensive diabetics显示文摘	KHAN TM MARWAT MA REHMAN H	2005	J Ayub Med Coll Abbottabad2005，17，4：	1
17	Vincristine and bortezomib cause axon outgrowth and behavioral defects in larval zebrafish 显示文摘	Khan TM Benaich N Malone CF	2012	J Peripher Nerv Syst2012，17，1：	1
18	Preparation of brain - derived neurotrophic factor and neurotrophin - 3 - secreting schwam ceils by infection with a retuvizal vector 显示文摘	Sayers ST Khan N Ahmed TM	1998	T Mol Neurosci1998，10，2：	1
19	Intraosseous infusion and pulmonary fat embolism显示文摘	Hasan MY Kissoon N Khan TM Saldajeno V Goldstein J Murphy SP	2001	Pediatr Crit Care Med2001，2，2：	1
20	Mechanisms ofacquired crizotinib resistance in ALK -rearranged lungCancers 显示文摘	Katayama R Shaw AT Khan TM’	2012	Sci Transl Med2012，4，120：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示